Sheng‐Kai Liang

801 total citations
32 papers, 517 citations indexed

About

Sheng‐Kai Liang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sheng‐Kai Liang has authored 32 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Sheng‐Kai Liang's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Sheng‐Kai Liang is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Sheng‐Kai Liang collaborates with scholars based in Taiwan, United States and China. Sheng‐Kai Liang's co-authors include Jen‐Chung Ko, Meng‐Rui Lee, Li‐Ta Keng, Jin‐Yuan Shih, Yunfeng Chen, Jeff Jagoda, Ari Glezer, Lih‐Yu Chang, Chia‐Hao Chang and Min‐Shu Hsieh and has published in prestigious journals such as Analytical Biochemistry, Oncogene and Scientific Reports.

In The Last Decade

Sheng‐Kai Liang

29 papers receiving 505 citations

Peers

Sheng‐Kai Liang
Xing Lv China
Buffy Hudson‐Curtis United States
Sharon L. Ho Canada
Fanzheng Meng China
Bei Ye China
Omid Forouzan United States
Haruo Shimizu Japan
Matthew Brown United States
Sho Fukuda Japan
Peilu Li China
Xing Lv China
Sheng‐Kai Liang
Citations per year, relative to Sheng‐Kai Liang Sheng‐Kai Liang (= 1×) peers Xing Lv

Countries citing papers authored by Sheng‐Kai Liang

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Kai Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Kai Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Kai Liang more than expected).

Fields of papers citing papers by Sheng‐Kai Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Kai Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Kai Liang. The network helps show where Sheng‐Kai Liang may publish in the future.

Co-authorship network of co-authors of Sheng‐Kai Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Kai Liang. A scholar is included among the top collaborators of Sheng‐Kai Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Kai Liang. Sheng‐Kai Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liang, Sheng‐Kai, Wei‐Yu Liao, Jin‐Yuan Shih, et al.. (2024). Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia. 60. 101113–101113. 1 indexed citations
4.
Liang, Sheng‐Kai, Li‐Ta Keng, Meng‐Rui Lee, et al.. (2023). Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients. Cancer Medicine. 12(17). 17993–18004. 3 indexed citations
5.
Chen, Guan‐Yuan, Sheng‐Kai Liang, Yu-Feng Wei, Te−I Weng, & Kuan‐Yu Chen. (2023). Determining plasma and cerebrospinal fluid concentrations of EGFR-TKI in lung cancer patients. Analytical Biochemistry. 669. 115115–115115. 4 indexed citations
6.
Liang, Sheng‐Kai, Yueh‐Feng Wen, Chia‐Hao Chang, et al.. (2021). Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer. Cancers. 13(6). 1431–1431. 74 indexed citations
7.
8.
Liang, Sheng‐Kai, Hsiang‐Lin Song, Xiang Yao, et al.. (2021). FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis. Oncogene. 40(30). 4847–4858. 35 indexed citations
9.
Keng, Li‐Ta, Sheng‐Kai Liang, Yueh‐Feng Wen, et al.. (2021). Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation. Frontiers in Medicine. 8. 675103–675103. 3 indexed citations
10.
Wang, Yanzhi, et al.. (2021). LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling. Journal of Bone and Mineral Metabolism. 39(4). 534–546. 19 indexed citations
11.
Liang, Sheng‐Kai, Li‐Hsin Chien, Gee‐Chen Chang, et al.. (2021). Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers. Frontiers in Oncology. 11. 753788–753788. 4 indexed citations
12.
Keng, Li‐Ta & Sheng‐Kai Liang. (2018). Albers-Schönberg disease. The Korean Journal of Internal Medicine. 34(5). 1167–1168. 2 indexed citations
13.
Liang, Sheng‐Kai, Meng‐Rui Lee, Wei‐Yu Liao, et al.. (2018). Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study. Oncotarget. 9(34). 23749–23760. 17 indexed citations
14.
Keng, Li‐Ta, Kuei‐Pin Chung, Shu‐Yung Lin, et al.. (2017). Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation. Scientific Reports. 7(1). 2148–2148. 8 indexed citations
15.
Liang, Sheng‐Kai, Min‐Shu Hsieh, Meng‐Rui Lee, et al.. (2017). Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma. Oncotarget. 8(52). 90430–90443. 54 indexed citations
16.
Pan, Chun‐Hao, et al.. (2016). Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells. BMC Cancer. 16(1). 857–857. 52 indexed citations
17.
Lee, Meng‐Rui, et al.. (2015). Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000–2014. International Journal of Antimicrobial Agents. 46(4). 439–445. 20 indexed citations
18.
Lee, Meng‐Rui, Jen‐Chung Ko, Sheng‐Kai Liang, et al.. (2014). Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates. International Journal of Antimicrobial Agents. 43(5). 438–441. 14 indexed citations
19.
Keng, Li‐Ta, Chin‐Chung Shu, Sheng‐Kai Liang, et al.. (2013). Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy. Journal of Infection. 67(4). 294–302. 46 indexed citations
20.
Chen, Yunfeng, et al.. (2000). Manipulating pattern factor using synthetic jet actuators. 38th Aerospace Sciences Meeting and Exhibit. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xing Lv Breakdown of academic impact, for papers by Buffy Hudson‐Curtis Breakdown of academic impact, for papers by Sharon L. Ho Breakdown of academic impact, for papers by Fanzheng Meng Breakdown of academic impact, for papers by Bei Ye Breakdown of academic impact, for papers by Omid Forouzan Breakdown of academic impact, for papers by Haruo Shimizu Breakdown of academic impact, for papers by Matthew Brown Breakdown of academic impact, for papers by Sho Fukuda Breakdown of academic impact, for papers by Peilu Li
Rankless by CCL
2026